Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Human genome deadline cut by two years

washington

The main US government sponsor of the Human Genome Project adopted an ambitious plan this week to finish sequencing the human genome by 2003, two years ahead of the original target.

The advisory council of the National Human Genome Research Institute (NHGRI) unanimously approved the plan, which sets as an interim goal the production by the end of 2001 of a ‘working draft’ of the genome that is at least 90 per cent complete (see Nature 393, 399; 1998 .)

The plan also calls for one-third of the genome to be completely sequenced by 2001. It calls for a focus on gene-rich regions as this interim goal is reached, and suggests that an international peer review process be set up immediately to prioritize regions to be sequenced, based on the needs of the international research community.

The plan, which sets goals for the entire federal effort between 1999 and 2003, is to be published in full next month. As recently as May, a draft version contained no reference to advancing the target date to 2003.

“We are talking about big and ambitious, even audacious, plans,” said Francis Collins, the NHGRI director, at a meeting of the advisory council on Monday (14 September). He described the new targets as “a stretch”. But he said the accelerated timetable was vital because every year that passes without the genome sequenced was “an opportunity lost for biomedical research across the board”. Collins added: “This is not a time to be conservative, cautious or to coast along.”

The new plan will require government-sponsored sequencers to double or even triple their output. But Collins said that it does not rely on the institute receiving additional funding from Congress beyond regular annual increases “in the neighbourhood of 10 per cent”.

To accommodate the new goals, he said, the proportion of the institute's $218 million budget spent on sequencing will grow from its current 45 per cent to 60 or 65 per cent by 2001.

Collins denied that the plan was formulated in reaction to the announcement in May by Celera Genomics, a company headed by genome sequencer J. Craig Venter, that it aims to sequence the genome within three years (see Nature 393, 101; 1998 ). “This is action, not reaction,” said Collins. But he added that the goal of producing a ‘working draft’ presents “great potential for collaboration” with Celera.

Venter agrees. He calls the government's plan for the draft “a tremendously positive development”. It “certainly alleviates any critics' questions or problems about [Celera's] ability to assemble the whole genome”.

Celera's plan has been questioned because it relies on the technique of whole genome ‘shotgun’ sequencing that many predict will present significant reassembly problems. The rapid production of a ‘working draft’ by the government would provide mapping information of great value to the private reassembly efforts.

David Bentley, head of human genetics at the Sanger Centre in Cambridge, United Kingdom, which will compile one-third of the draft sequence due by 2001, warmly endorsed the new plan, and called the international peer review proposal “excellent”. He added: “There is a need to have some sort of process of reviewing all these claims to ensure that the right regions are done, and the best use is made of the resources.”

Collins stressed that the ‘working draft’ was not a “throwaway” product, but an intermediate step to the completion of the genome. “There should be no additional expense created” by its generation, he said.

The Department of Energy has approved the five-year plan. The department, a joint author of the plan, is the other federal sponsor of the genome project.

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wadman, M. Human genome deadline cut by two years. Nature 395, 207 (1998). https://doi.org/10.1038/26061

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/26061

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing